Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of GSK1605786A in active ulcerative colitis
2011-002818-37Phase 2Completed
- Sponsor
- GSK
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in autoimmune colitis comparing GSK1605786A 500 mg BID with Placebo (2 arms). Primary endpoint: Ordinal clinical response by MAYO score at week 12. Started Oct 2011; status: completed.
02
Drugs
vercirnon
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on 2011-002818-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002818-37.